第1段
A 板块|小众选择,可能很快进入普通家庭
查看译文
A 板块|小众选择,可能很快进入普通家庭
今天先带着问题读原文,再进入段落精读工作台,最后用自测、翻译和仿写确认自己真正掌握了什么。
扫码付款后,请添加小助理微信:foxwulihua4。
发送付款截图,小助理会发你学习专属码。
输入专属码后,可查看当前班期已解锁内容。
学习专属码
首次使用请输入小助理发你的专属码;换手机或电脑时输入同一个专属码,就能同步学习记录。
今晚把文章里的答案分成三类:确定答案、风险估计、政策选择。看到near-certainty、risk estimates、relative terms、absolute ones时,先确认作者在谈哪一层。B板块最后的rather than不是语法装饰,它把“技术有限”导向“加强披露”,而非“全面禁止”。
A 板块|小众选择,可能很快进入普通家庭
For now, the debate is a niche concern. The startups mostly cater to the rich, famous and odd. Yet that will change. A wave of investment means that the cost of IVF is likely to fall. If offered embryo screening at the same time, many couples will take it. One survey suggests that three-quarters of Americans support screening embryos for diseases; about a third say the same for non-disease traits. And that is before competitive pressure kicks in. Who wants to see their child bested by genetically selected classmates?
There are indeed reasons for caution. Polygenic scores are tricky. For many diseases caused by a single gene, testing offers near-certainty: if an embryo has the material, it will develop the condition. Yet an assessment of multiple genes leads to risk estimates, rather than a binary answer—and such estimates are more accurate for people with European ancestry, because they are better represented in genetic databases.
B 板块|技术有边界,政策未必需要一刀切
Further caveats are in order. Risk reductions can look large in relative terms but be small in absolute ones, particularly for rare diseases. Selecting for some traits may raise the risk of other less desirable ones. Even for highly genetically determined traits like height, parents remain limited by the range found in their own embryos.
These facts are an argument for disclosure, however, rather than legal restrictions or outright bans. If companies want to offer polygenic scoring, they must adequately communicate the technology's limits and risks. They should also let their tests undergo independent scrutiny. This will not scupper a nascent business, since the startups are not, as some critics allege, selling snake oil. A study in 2019 found that parents choosing from among ten embryos may be able to boost their child's height by 1-6cm and IQ by between one and seven points—with tech that is now nearly a decade old. As genetic databases get better and cover broader populations, and AI draws out the relationship between genes and traits, scores will improve.
请先自己翻译下面这句话。不要急着追求漂亮,先把主干、修饰关系和语境逻辑译清楚。
下一步:等 8:00 解锁后,再看讲义、完成训练和打卡。现在不用提前做这里。
请先完成 21:00 预习包:英文原文、预习题和长难句挑战。
精读讲义将在第二天早上 08:00 自动解锁。解锁后可查看原文标亮版、词汇注释、长难句解析和老师带读。
每段原文下面直接展开译文、词汇和长难句。
这篇社论没有回避技术限制。A板块先说明筛查可能普及,再把单基因检测和多基因评分分开:前者在某些疾病上接近确定,后者只能给概率,而且欧洲裔数据更多,准确度也更高。B板块继续加限制:相对风险下降可能很显眼,换成绝对风险却很小;选一个性状还可能牵动另一个风险。可作者没有由此跳到全面禁止。它给出的政策顺序是披露局限、接受独立审查,让夫妇在知道不确定性的前提下选择。
A 板块|小众选择,可能很快进入普通家庭
A 板块|小众选择,可能很快进入普通家庭
For now, the debate is a niche concern. The startups mostly cater to the rich, famous and odd. Yet that will change. A wave of investment means that the cost of IVF is likely to fall. If offered embryo screening at the same time, many couples will take it. One survey suggests that three-quarters of Americans support screening embryos for diseases; about a third say the same for non-disease traits. And that is before competitive pressure kicks in. Who wants to see their child bested by genetically selected classmates?
就目前而言,这场争论仍属小众议题。相关初创公司的客户群主要集中在富人、名人以及少数另类人士之中。然而,这一局面终将改变。随着大量资本涌入,试管婴儿的费用有望大幅降低。若在此基础上同步提供胚胎筛查服务,许多夫妇都会选择使用。一项调查显示,四分之三的美国人支持通过胚胎筛查来预防疾病;约三分之一的人也支持筛查非疾病性状。而这一切,还是在竞争压力真正显现之前。试想,又有哪位父母愿意眼睁睁看着自己的孩子输给那些经过基因优选的同龄人呢?
cater to面向并满足……需求。
✨ 拓展/考点:常见cater to wealthy customers/special interests,有时带“迎合”意味,需看语气。
There are indeed reasons for caution. Polygenic scores are tricky. For many diseases caused by a single gene, testing offers near-certainty: if an embryo has the material, it will develop the condition. Yet an assessment of multiple genes leads to risk estimates, rather than a binary answer—and such estimates are more accurate for people with European ancestry, because they are better represented in genetic databases.
确实存在需要谨慎的理由。多基因评分并不简单。对于许多由单一基因引发的疾病,检测结果几乎是确定的:若胚胎携带相关基因,便会发展为该病症。然而,对多个基因的综合评估得出的是风险概率,而非非此即彼的答案。此类估计对欧洲裔人群更为准确,因为他们在基因数据库中的数据更为充分。
near-certainty接近确定的结果。
✨ 拓展/考点:near-仍保留边界,不能翻成“百分之百确定”。
binary answer非此即彼的答案。
✨ 拓展/考点:binary指两种状态。多基因评分输出概率,不是简单的“会/不会”。
原句再现 Yet an assessment of multiple genes leads to risk estimates, rather than a binary answer—and such estimates are more accurate for people with European ancestry, because they are better represented in genetic databases.
结构拆解 破折号前主干是assessment leads to risk estimates,rather than纠正输出不是二元答案。破折号后继续限制准确度,because解释欧洲裔人群在数据库中代表性更高;they回指people。
翻译点拨 中文拆成两句最稳:先说“只能给概率”,再说“对谁更准、为什么”。别让破折号后的偏差说明被埋进长定语。
推荐译法 然而,对多个基因的综合评估得出的是风险概率,而非非此即彼的答案。此类估计对欧洲裔人群更为准确,因为他们在基因数据库中的数据更为充分。
B 板块|技术有边界,政策未必需要一刀切
B 板块|技术有边界,政策未必需要一刀切
Further caveats are in order. Risk reductions can look large in relative terms but be small in absolute ones, particularly for rare diseases. Selecting for some traits may raise the risk of other less desirable ones. Even for highly genetically determined traits like height, parents remain limited by the range found in their own embryos.
还需要进一步补充说明。风险降低在相对数值上可能看起来很显著,但在绝对数值上可能微乎其微,尤其是对于罕见疾病而言。筛选某些性状可能会增加其他不良性状出现的风险。即便是对于像身高这类受基因高度决定的性状,父母的选择空间仍然受限于自身胚胎所呈现的遗传范围。
caveat限定条件;提醒。
✨ 拓展/考点:评论文常用with a caveat、caveats are in order给前文判断加边界。
These facts are an argument for disclosure, however, rather than legal restrictions or outright bans. If companies want to offer polygenic scoring, they must adequately communicate the technology's limits and risks. They should also let their tests undergo independent scrutiny. This will not scupper a nascent business, since the startups are not, as some critics allege, selling snake oil. A study in 2019 found that parents choosing from among ten embryos may be able to boost their child's height by 1-6cm and IQ by between one and seven points—with tech that is now nearly a decade old. As genetic databases get better and cover broader populations, and AI draws out the relationship between genes and traits, scores will improve.
然而,这些事实支持的是信息披露,而非法律限制或全面禁止。若企业希望提供多基因评分服务,就必须充分告知用户该技术的局限性与潜在风险,同时应允许其测试接受独立审查。这并不会扼杀这一新兴行业,毕竟这些初创公司并非如部分批评者所言在兜售假药。2019年的一项研究表明,在十个胚胎中进行筛选的父母,有望将孩子的身高提升1至6厘米、智商提高1至7分,而这还是基于如今已近十年前的技术。随着基因数据库持续扩充、覆盖更广泛的人群,加之人工智能深入解析基因与性状之间的关联,多基因评分的准确性将不断提升。
原句再现 As genetic databases get better and cover broader populations, and AI draws out the relationship between genes and traits, scores will improve.
结构拆解 As统领两个并列变化:数据库质量提高并覆盖更多人群;AI进一步提取基因与性状关系。主句scores will improve落在最后。
翻译点拨 先把两项条件并列清楚,再说评分提高。draw out不是简单“画出”,而是从复杂数据中提炼关系。
推荐译法 随着基因数据库持续扩充、覆盖更广泛的人群,加之人工智能深入解析基因与性状之间的关联,多基因评分的准确性将不断提升。
niche concern小众议题。
✨ 拓展/考点:niche强调当前涉及人少、市场窄。作者紧接Yet that will change,把当下规模与未来影响分开。
competitive pressure kicks in竞争压力开始显现。
✨ 拓展/考点:kick in表示药效、规则或压力开始起作用。父母比较心理可能扩大技术采用。
in relative/absolute terms按相对/绝对数值计算。
✨ 拓展/考点:从2%降到1%是相对下降50%,绝对只下降1个百分点。医学风险题最常在这里偷换。
outright ban全面禁止。
✨ 拓展/考点:outright强调彻底、没有例外,可搭配ban/rejection/victory。
independent scrutiny独立审查。
✨ 拓展/考点:scrutiny不是普通“看一看”,而是细致、带质疑地核验。
sell snake oil兜售假药;卖骗人的东西。
✨ 拓展/考点:snake-oil salesman来自推销无效万能药的人,现可泛指夸大技术或产品效果。
第1段先解释今天的小众争论为什么会变成大众选择——IVF成本下降,筛查被同时提供,再加上“别人会不会替孩子选择”这种竞争压力,都会把采用率往上推。
采用率上去了,技术本身能给出什么答案?第2段先区分确定性:单基因疾病有时接近“有或没有”这种确定答案,多基因评分却只能给风险估计;欧洲血统在数据库中代表性更高,同一工具用在不同人群身上,准确度也不一样。
概率这东西很容易被误读,第3段教你怎么看风险数字:相对降幅可能很大,绝对变化却很小;降低一种风险,还可能提高另一种风险;就连身高这种性状,父母也只能在已有胚胎的范围内选择,不是想要多高就有多高。
第4段把这些限制转换成政策——作者主张企业充分披露、接受独立审查,并没有把不确定性直接推成全面禁止。2019年的研究和未来数据库的持续改进,也说明这项技术并非毫无能力。扩散的压力、技术的边界、数字的边界、政策的选择,四段依次走完。面对一项新技术,风险真实不等于只有禁令这一种答案——关键是让概率、偏差和代价,真正进入决策。
These facts are an argument for X, rather than Y.(这些事实支持X,而非Y。)
这是社论里很实用的政策句式:先承认问题,再说明问题究竟支持哪种应对方式,避免从“有风险”直接跳到“全面禁止”。
训练区会在 8:00 精读讲义解锁后开放。请先完成预习,第二天看完讲义后再进入试译、参考译文和自测练习。
这里不是重复做题,而是把刚学过的词义、结构和译法真正用出来。
先自测,再翻译、仿写,最后保存今日打卡。
自测原文
A 板块|小众选择,可能很快进入普通家庭
For now, the debate is a niche concern. The startups mostly cater to the rich, famous and odd. Yet that will change. A wave of investment means that the cost of IVF is likely to fall. If offered embryo screening at the same time, many couples will take it. One survey suggests that three-quarters of Americans support screening embryos for diseases; about a third say the same for non-disease traits. And that is before competitive pressure kicks in. Who wants to see their child bested by genetically selected classmates?
There are indeed reasons for caution. Polygenic scores are tricky. For many diseases caused by a single gene, testing offers near-certainty: if an embryo has the material, it will develop the condition. Yet an assessment of multiple genes leads to risk estimates, rather than a binary answer—and such estimates are more accurate for people with European ancestry, because they are better represented in genetic databases.
B 板块|技术有边界,政策未必需要一刀切
Further caveats are in order. Risk reductions can look large in relative terms but be small in absolute ones, particularly for rare diseases. Selecting for some traits may raise the risk of other less desirable ones. Even for highly genetically determined traits like height, parents remain limited by the range found in their own embryos.
These facts are an argument for disclosure, however, rather than legal restrictions or outright bans. If companies want to offer polygenic scoring, they must adequately communicate the technology's limits and risks. They should also let their tests undergo independent scrutiny. This will not scupper a nascent business, since the startups are not, as some critics allege, selling snake oil. A study in 2019 found that parents choosing from among ten embryos may be able to boost their child's height by 1-6cm and IQ by between one and seven points—with tech that is now nearly a decade old. As genetic databases get better and cover broader populations, and AI draws out the relationship between genes and traits, scores will improve.
请翻译: Yet an assessment of multiple genes leads to risk estimates, rather than a binary answer—and such estimates are more accurate for people with European ancestry, because they are better represented in genetic databases.
✍️ 下笔提示: 破折号前后拆两句;先写概率与二元答案的区别,再处理“对谁更准、为什么”。
模仿These facts are an argument for X, rather than Y.,写一句说明某组风险事实支持更精细的治理,而非简单禁令。
✍️ 下笔提示: X与Y必须是同一政策问题的两种应对;保留an argument for...rather than...。
下一步:晚上回来这里看共性问题、典型误区和老师补充。现在可以先提交今天最卡的问题。
翻译门诊会根据当天学员提交到答疑池的问题,筛选高频疑问、典型误区和老师补充提醒。
你可以先完成学习任务,并提交问题到答疑池。
20:30 翻译门诊不是重复上午讲义,而是根据学员提交的问题,补充讲解高频疑问、典型误区和老师提醒。
今晚重点看三处。
第一,near-certainty仍不是100%。外刊在科学问题上会保留最后一点误差空间,中文不要顺手改成“完全确定”。
第二,相对风险与绝对风险必须看基数。罕见病风险从万分之二降到万分之一,相对下降50%,绝对只少万分之一。宣传最容易只展示前者。
第三,社论承认技术局限,却主张披露和独立审查优先于禁令。读社论时要把“问题是什么”和“问题支持何种政策”分开,中间不能自动跳步。
新版框架:30天打卡|20天正课|4周完成。老师端重点放在:内容状态、发布物料、答疑取舍、校对清单和学员问题整理。
今晚 Day12 预习包已更新。先不要看译文,完成三件事:读原文、做预习题、试译长难句。明早讲义会先给标亮版、词汇注释和长难句解析,最后再放参考译文。
Day12 午间提醒:今天重点看三个地方:关键词怎么用、句子逻辑怎么转、长难句怎么拆。先自己判断,再回到讲义里对照。